Alzheimer's disease is a progressive disease that occurs when nerve cells in the brain are destroyed and the brain atrophies. As the disease progresses, cognitive function declines and various peripheral symptoms develop, eventually leading to a state where the patient requires nursing care in general daily life. The medicines developed by the company are oral low-molecule drugs that treat the various pathological conditions of Alzheimer's disease, making them inexpensive and possible to treat at home. By improving patient satisfaction with treatment, reducing the burden on caregivers, and optimizing medical costs for the entire country, we aim to create an impact that extends healthy lifespans and reduces economic losses.